Literature DB >> 29758336

Hepatic manifestations of telomere biology disorders.

Mrinal M Patnaik1, Patrick S Kamath2, Douglas A Simonetto3.   

Abstract

A 51-year-old Caucasian male was referred for evaluation of variceal bleeding. Laboratory tests were remarkable for mild thrombocytopenia and moderate alkaline phosphatase elevation. Synthetic liver function was well preserved. Abdominal computed tomography scan revealed moderate splenomegaly, gastric varices, and normal hepatic contour. A transjugular liver biopsy was performed revealing findings of nodular regenerative hyperplasia with no significant fibrosis or necroinflammatory activity. Hepatic venous pressure gradient was elevated at 31 mmHg, consistent with clinically significant portal hypertension. The clinical course was complicated by refractory gastric variceal bleeding requiring a surgical portosystemic shunt. Approximately seven years after the initial presentation, the patient developed progressive dyspnoea and a diagnosis of idiopathic pulmonary fibrosis was made. Contrast-enhanced echocardiogram was not suggestive of hepatopulmonary syndrome or portopulmonary hypertension. Given this new diagnosis a telomere biology disorder was suspected. A flow-fluorescence in situ hybridisation analysis for telomere length assessment revealed telomere lengths below the first percentile in both lymphocytes and granulocytes. Next generation sequencing analysis identified a heterozygous mutation involving the hTERT gene (Histidine983Threonine). The lung disease unfortunately progressed in the subsequent two years, leading to the patient's death nine years after his initial presentation with portal hypertension. During those nine years two brothers also developed idiopathic pulmonary fibrosis. The questions that arise from this case include.
Copyright © 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cryptogenic cirrhosis; Nodular regenerative hyperplasia; Portal hypertension; Telomere; Telomere biology disorders

Mesh:

Year:  2018        PMID: 29758336     DOI: 10.1016/j.jhep.2018.05.006

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  5 in total

Review 1.  Recognizing genetic disease: A key aspect of pediatric pulmonary care.

Authors:  Lael M Yonker; Megan H Hawley; Peter P Moschovis; Mengdi Lu; T Bernard Kinane
Journal:  Pediatr Pulmonol       Date:  2020-07

Review 2.  The role of telomeres and telomerase in cirrhosis and liver cancer.

Authors:  Jean-Charles Nault; Massih Ningarhari; Sandra Rebouissou; Jessica Zucman-Rossi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-06-28       Impact factor: 46.802

3.  Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population.

Authors:  Puru Rattan; Daniel D Penrice; Joseph C Ahn; Alejandro Ferrer; Mrinal Patnaik; Vijay H Shah; Patrick S Kamath; Abhishek A Mangaonkar; Douglas A Simonetto
Journal:  Hepatol Commun       Date:  2021-08-28

4.  Recombinant Oncolytic Adenovirus Combined with Cyclophosphamide Induces Synergy in the Treatment of Breast Cancer in vitro and in vivo.

Authors:  Jing Wang; Shuting Zuo; Yan Zhang; Shanzhi Li; Ying Shi; Tonghua Du; Jicheng Han; Ningyi Jin; Yiquan Li; Xiao Li
Journal:  Cancer Manag Res       Date:  2022-09-15       Impact factor: 3.602

5.  Chemovirotherapy of Lung Squamous Cell Carcinoma by Combining Oncolytic Adenovirus With Gemcitabine.

Authors:  Xing Liu; Zhiguang Yang; Yiquan Li; Yilong Zhu; Wenjie Li; Shanzhi Li; Jing Wang; Yingli Cui; Chao Shang; Zirui Liu; Gaojie Song; Ce Li; Xiao Li; Guoguang Shao; Ningyi Jin
Journal:  Front Oncol       Date:  2020-02-25       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.